Aliskiren
  
Side effects 
	
		
Options: 
			
			Show MedDRA Preferred Terms
		
	
	
| Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 
| Headache | 6.71% - 11.2% |  |  | x | x | x |  |  |  |  | x | 
| Nasopharyngitis | 4.42% - 6.16% |  |  | x | x | x |  |  |  |  |  | 
| Arthralgia | common |  |  |  |  | x |  |  | x | x | x | 
| Dizziness | common |  |  | x | x |  |  |  | x | x | x | 
| Hyperkalaemia | common |  |  |  |  |  |  |  | x | x | x | 
| Back pain | 3.08% - 4.77% |  |  | x | x | x |  |  |  |  |  | 
| Cough | uncommon, 2.83% - 9.48% |  | x | x | x | x | x | x |  | x | x | 
| Diarrhoea | common, 1.66% - 3.82% |  | x | x | x | x | x | x | x | x | x | 
| Oedema peripheral | postmarketing — 3.08% - 5.56% |  | x |  | x | x |  |  | x | x | x | 
| Bronchitis | 0.948% - 3.1% |  |  |  |  | x |  |  |  |  |  | 
| Toxic epidermal necrolysis | postmarketing, uncommon |  | x |  |  |  |  |  | x | x | x | 
| Rash | uncommon |  | x | x | x | x | x | x | x | x | x | 
| Hypotension | uncommon |  |  |  |  |  |  |  | x | x | x | 
| Renal failure acute | uncommon |  |  |  |  |  | x | x | x | x | x | 
| Palpitations | uncommon |  |  |  |  |  |  |  |  | x | x | 
| Pruritus | postmarketing, uncommon |  | x |  |  |  |  |  | x | x | x | 
| Stevens-Johnson syndrome | postmarketing, uncommon |  | x |  |  |  |  |  |  | x | x | 
| Urticaria | postmarketing, uncommon |  | x |  |  |  |  |  | x | x | x | 
| Renal impairment | uncommon |  |  |  |  |  |  |  | x | x | x | 
| Anaphylactic shock | postmarketing |  | x |  |  |  |  |  |  | x | x | 
| Angioedema | postmarketing, rare |  | x | x | x | x | x | x | x | x | x | 
| Colon cancer | 0.05% |  |  |  |  | x |  |  |  |  |  | 
| Hypersensitivity | postmarketing, rare |  | x |  | x | x | x | x | x | x | x | 
| Erythema | postmarketing, rare |  | x |  |  |  |  |  |  | x | x | 
| Hepatic function abnormal | postmarketing |  | x |  |  |  |  |  |  |  | x | 
| Haemoglobin decreased | rare |  |  |  |  |  |  |  | x | x | x | 
| Blood creatinine increased | postmarketing, rare |  |  |  | x |  |  |  | x | x | x | 
| Haematocrit decreased | rare |  |  |  |  |  |  |  | x | x | x | 
| Abdominal pain |  |  | x | x | x | x |  |  |  |  |  | 
| Anaemia |  |  | x | x | x | x | x | x | x | x | x | 
| Asthenia |  |  |  |  |  | x |  |  |  |  |  | 
| Neck pain |  |  |  |  |  | x |  |  |  |  |  | 
| Connective tissue disorder |  |  |  |  |  |  |  |  | x | x | x | 
| Constipation |  |  |  |  |  | x |  |  |  |  |  | 
| Dyspepsia |  |  | x | x | x | x |  |  |  |  |  | 
| Oedema |  |  | x | x | x | x |  |  |  |  |  | 
| Epistaxis |  |  |  |  |  | x |  |  |  |  |  | 
| Fatigue |  |  |  | x | x |  |  |  |  |  |  | 
| Gastrooesophageal reflux disease |  |  | x | x | x | x |  |  |  |  |  | 
| Gastrointestinal disorder |  |  |  |  |  |  | x | x | x | x | x | 
| Gout |  |  | x | x | x |  |  |  |  |  |  | 
| Cardiac disorder |  |  |  |  |  |  |  |  |  | x | x | 
| Hepatitis |  |  |  |  |  |  |  |  |  |  | x | 
| Immune system disorder |  |  |  |  |  |  |  |  | x | x | x | 
| Influenza |  |  |  |  |  | x |  |  |  |  |  | 
| Jaundice |  |  |  |  |  |  |  |  |  |  | x | 
| Calculus of kidney |  |  | x | x | x |  |  |  |  |  |  | 
| Liver disorder |  |  |  |  |  |  |  |  |  |  | x | 
| Mediastinal disorder |  |  |  |  |  |  |  |  |  | x | x | 
| Myositis |  |  | x | x | x |  |  |  |  |  |  | 
| Nausea |  |  |  |  |  | x |  |  |  |  |  | 
| Nervous system disorder |  |  |  |  |  |  |  |  | x | x |  | 
| Pain in extremity |  |  |  |  |  | x |  |  |  |  |  | 
| Rhabdomyolysis |  |  | x | x | x |  |  |  |  |  |  | 
| Rhinitis |  |  |  |  |  | x |  |  |  |  |  | 
| Convulsion |  |  | x |  | x |  |  |  |  |  |  | 
| Shoulder pain |  |  |  |  |  | x |  |  |  |  |  | 
| Muscle spasms |  |  |  |  |  | x |  |  |  |  |  | 
| Swelling |  |  |  |  |  |  | x | x | x | x | x | 
| Loss of consciousness |  |  | x | x | x |  |  |  |  |  |  | 
| Upper respiratory tract infection |  |  |  | x | x |  |  |  |  |  |  | 
| Uric acid level increased |  |  | x | x | x |  |  |  |  |  |  | 
| Urinary tract infection |  |  |  |  |  | x |  |  |  |  |  | 
| Urinary tract disorder |  |  |  |  |  |  |  |  | x | x | x | 
| Angiopathy |  |  |  |  |  |  |  |  | x | x | x | 
| Vertigo |  |  |  |  |  | x |  |  |  |  |  | 
| Hepatic failure |  |  |  |  |  |  |  |  |  |  | x | 
| Periorbital oedema |  |  | x | x | x |  |  |  |  |  |  | 
| Blood urea increased |  |  | x | x | x | x |  |  |  |  |  | 
| Creatinine increased |  |  |  |  |  | x |  |  |  |  |  | 
| Swelling face |  |  |  |  |  | x |  |  |  |  |  | 
| Unspecified disorder of skin and subcutaneous tissue |  |  |  |  |  |  | x | x | x | x | x | 
| Diabetic |  |  |  | x | x | x | x | x |  |  |  | 
| Hepatobiliary disease |  |  |  |  |  |  |  |  |  |  | x | 
| Tonic-clonic seizures |  |  | x | x | x |  |  |  |  |  |  | 
| Serum potassium increased |  |  | x | x | x | x | x | x | x | x | x | 
| Cough increased |  |  | x | x | x |  |  |  |  |  |  | 
| Increased effect |  |  |  |  |  | x |  |  |  |  |  | 
| Serum creatinine increased |  |  |  |  |  | x |  |  |  |  |  | 
| Dry cough |  |  |  |  |  | x |  |  |  |  |  | 
| Raised serum uric acid |  |  | x | x | x |  |  |  |  |  |  | 
| Pharyngolaryngeal pain |  |  |  |  |  | x |  |  |  |  |  | 
| Insomnia |  |  |  |  |  | x |  |  |  |  |  | 
| Uncontrolled hypertension |  |  | x | x | x |  |  |  |  |  |  | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 32 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 29 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 33 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 39 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 12 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 12 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 27 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 34 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 40 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |